Janssen-Cilag Ltd

Information

Name

Janssen-Cilag Ltd

Type

Company

Roles

Supplier

Company Size

Large

Company Number

Incorporation Date

Website

http://www.janssen.co.uk

Address

HighWycombe

United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Janssen-Cilag Ltd
Sign up free

Contracts awarded to Janssen-Cilag Ltd

The contracts that Janssen-Cilag Ltd have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 8 hours ago

NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025

NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

£4,108,145,000 Bids close: 3 months ago
Award

Published 8 hours ago

NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025

NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025<br/>CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 <br/>CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026

£24
Award

Published 5 days ago

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

NHS Framework Agreement for Branded Medicines - Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 Offer reference number: CM/PHR/24/5718 CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines - Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines - Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months.

£261,895,933 Bids close: 4 months ago
Award

Published 5 days ago

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025<br/>CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines – Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027<br/>CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines – Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026

£29
Award

Published 2 months ago

Biologic and Biosimilar Medicines

Biologic and Biosimilar Medicines

£96,642,400
Award

Published 3 months ago

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender

Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025 Offer reference number: CM/PHR/22/5683 NHS Framework Agreement for Branded Medicines - Proprietary Category Tender: Period of Framework Agreement: 01 May 2025 to 30 April 2029

£1,241,520,444 Bids close: 7 months ago

Contacts

+44 1494567543

Statistics (1 Year)

Contracts Won

Total Won

£110,458,978

Average Win

£55,229,489

Janssen-Cilag Ltd

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Janssen-Cilag Ltd

NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025

NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025

Biologic and Biosimilar Medicines

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win